carbamates has been researched along with Hyperlipemia in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both repaglinide and metformin were effective in glycaemic control in new onset patients with type 2 diabetes in China." | 2.79 | Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China. ( Liao, Y; Liu, LY; Liu, W; Ma, J; Tao, T; Wu, PH, 2014) |
| " Modification of the core regiochemistry and stereochemistry significantly affected the potency, metabolic stability, and oral bioavailability of the inhibitors, as did the variation of a pendent arylmethyl P3 group." | 1.35 | 2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects. ( Chen, HJ; Colletti, L; Degoey, DA; Dekhtyar, T; Flentge, CA; Flosi, WJ; Grampovnik, DJ; Kati, WM; Kempf, DJ; Klein, LL; Mamo, M; Marsh, KC; Mo, H; Molla, A; Morfitt, DC; Nguyen, B; Randolph, JT; Schmidt, JM; Stoll, V; Swanson, SJ; Yeung, CM, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, J | 1 |
| Liu, LY | 1 |
| Wu, PH | 1 |
| Liao, Y | 1 |
| Tao, T | 1 |
| Liu, W | 1 |
| Degoey, DA | 2 |
| Grampovnik, DJ | 1 |
| Flentge, CA | 1 |
| Flosi, WJ | 1 |
| Chen, HJ | 1 |
| Yeung, CM | 1 |
| Randolph, JT | 2 |
| Klein, LL | 2 |
| Dekhtyar, T | 1 |
| Colletti, L | 1 |
| Marsh, KC | 1 |
| Stoll, V | 1 |
| Mamo, M | 1 |
| Morfitt, DC | 1 |
| Nguyen, B | 1 |
| Schmidt, JM | 1 |
| Swanson, SJ | 1 |
| Mo, H | 1 |
| Kati, WM | 1 |
| Molla, A | 1 |
| Kempf, DJ | 2 |
| Waring, JF | 1 |
| Ciurlionis, R | 1 |
| Marsh, K | 1 |
| Spear, B | 1 |
| Lattuada, E | 1 |
| Lanzafame, M | 1 |
| Grosso, C | 1 |
| Soldani, F | 1 |
| Corsini, F | 1 |
| Storato, S | 1 |
| Vento, S | 1 |
| Tentolouris, N | 1 |
| Kolia, M | 1 |
| Tselepis, AD | 1 |
| Perea, D | 1 |
| Kitsou, E | 1 |
| Kyriaki, D | 1 |
| Tambaki, AP | 1 |
| Karabina, SP | 1 |
| Sala, C | 1 |
| Fragoulopoulos, E | 1 |
| Katsilambros, N | 1 |
| el-Batran, SA | 1 |
| el-Shenawy, SM | 1 |
| Nofal, SM | 1 |
| Abdel-Salam, OM | 1 |
| Arbid, MS | 1 |
| Kapoor, JR | 1 |
| Walton, KW | 1 |
| Craig, GM | 1 |
| Prior, P | 1 |
| Waterhouse, JA | 1 |
| Skilton, J | 1 |
3 trials available for carbamates and Hyperlipemia
| Article | Year |
|---|---|
Comparison of metformin and repaglinide monotherapy in the treatment of new onset type 2 diabetes mellitus in China.
Topics: Body Mass Index; Carbamates; China; Combined Modality Therapy; Diabetes Mellitus, Type 2; Diet, Diab | 2014 |
Lack of effect of acute repaglinide administration on postprandial lipaemia in patients with type 2 diabetes mellitus.
Topics: Analysis of Variance; Blood Glucose; C-Peptide; Carbamates; Cholesterol; Diabetes Mellitus, Type 2; | 2003 |
Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
Topics: Arteriosclerosis Obliterans; Blood Cell Count; Bradykinin; Carbamates; Cholesterol; Clinical Trials | 1973 |
6 other studies available for carbamates and Hyperlipemia
| Article | Year |
|---|---|
2-Pyridyl P1'-substituted symmetry-based human immunodeficiency virus protease inhibitors (A-792611 and A-790742) with potential for convenient dosing and reduced side effects.
Topics: Animals; Binding Sites; Biological Availability; Caco-2 Cells; Carbamates; Cell Membrane Permeabilit | 2009 |
Identification of proteasome gene regulation in a rat model for HIV protease inhibitor-induced hyperlipidemia.
Topics: Animals; Atazanavir Sulfate; Carbamates; Disease Models, Animal; Drug Evaluation, Preclinical; Femal | 2010 |
Optimal fosamprenavir regimen to prevent lipid abnormalities.
Topics: Adult; Anti-HIV Agents; Carbamates; Drug Therapy, Combination; Female; Furans; HIV Protease Inhibito | 2009 |
Studies on the glycemic and lipidemic effect of monopril and losartan in normal and diabetic rats.
Topics: Alloxan; Animals; Blood Glucose; Blood Proteins; Carbamates; Cholesterol, LDL; Diabetes Mellitus, Ex | 2004 |
Postprandial hyperglycemia: are all sulfonylureas created equal?
Topics: Carbamates; Cyclohexanes; Glipizide; Humans; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Na | 2008 |
Metabolic profile of protease inhibitors studied.
Topics: Adipose Tissue; Animals; Carbamates; Disease Models, Animal; Furans; HIV Protease Inhibitors; Humans | 1999 |